Every parliamentary written question tabled by Lizzi Collinge this session, with the full answer and department. Back to the MP page.
Showing 1–14 of 14 · Department of Health and Social Care
What his department’s timeline is for deciding on the second wave of Modern Service Frameworks; and whether respiratory conditions will be considered.
I refer the hon. Member to the answer I gave to the hon. Member for City of Durham on 16 April 2026 to Question 125554.
What steps are being taken to ensure that individuals who have signed an S1 certificate and reside abroad are correctly recorded as non-resident for NHS purposes; and what measures are in place to prevent or recoup costs for any routine NHS treatment received in the UK by such individuals.
The Department publishes guidance for United Kingdom-issued S1 holders when moving and retiring abroad. UK-issued S1 holders should notify the relevant UK authorities, including their general practitioner, so their general practice registration can be removed. The full guidance can be found at the following link:www.gov.uk/guidance/moving-living-or-retiring-abroadThe S1 scheme is part of Reciprocal Healthcare Agreements between the UK and European Economic Area/Switzerland. In England, people with a registered UK S1 residing abroad are exempt from charging under the NHS (Charges to Overseas Visitors) Regulations 2015 while on a temporary visit. The National Health Service is required to check for the S1 entitlement before applying this exemption. There are therefore no measures in place to prevent or recoup costs from people holding a UK-registered S1. In exchange for providing this additional benefit for UK S1 holders, the UK receives a discount to costs for their healthcare in the country where they live.
What steps he is taking to increase the number of funded anaesthetic specialty training places over the next three years.
The 10-Year Health Plan, published on 3 July, set out that over the next three years we will create 1,000 new specialty training posts with a focus on specialties where there is the greatest need. We will set out next steps in due course.
What steps his Department is taking to update families affected by sodium valproate on compensation following publication of the Hughes Report; and when families should expect to receive details of (a) interim and (b) main payments.
The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report.
What steps his Department is taking to improve access to (a) gender identity and (b) trans healthcare services.
NHS England has established NHS Children and Young People's Gender Services in London, the North-West, and the South-West in 2024. A fourth service is planned to open in the East England region in January 2026. Work remains ongoing to establish commissioned services that provide a pathway for children and young people with gender incongruence in the other regions, by March 2027, on a phased basis.NHS England has increased the number of adult Gender Dysphoria Clinics in England from seven to 12, with the rollout of five new adult gender pilot clinics since July 2020. The rollout of these clinics is helping to tackle long waiting times.NHS England is currently carrying out a review of adult gender services, with the aim of producing an updated service specification. The review, which is chaired by Dr David Levy, will examine the model of care and operating procedures of each service, and will carefully consider experiences, feedback, and outcomes from clinicians and patients.
Whether his Department is taking steps to ensure that the national commitment to fracture liaison services is supported by a clear rollout plan.
I refer the Hon. Member to the answer I gave to the Hon. Member for Stockton West on 13 October 2025 to Question 77186.
Whether his Department has considered adjusting prescription charges for partial emergency supplies of medication.
There are currently no plans to adjust the prescription charge for emergency supplies of medicines. Under the Urgent Medicine Supply (UMS) element of the National Health Service Pharmacy First Service, NHS 111 can refer patients to a pharmacy to obtain an emergency supply of a medicine they regularly receive. Patients who receive an urgent supply under the UMS will be charged their usual prescription fee if they are not exempt. Where an emergency supply is made outside of the UMS, it is for the pharmacy to charge as they think is appropriate given that they will not be reimbursed by the NHS, as the medicine was not dispensed against an NHS prescription.
Whether he plans to review the duration of medical exemption certificates for people with (a) type 1 diabetes and (b) other lifelong conditions.
Medical exemption certificates allow people with certain medical conditions to obtain their NHS prescriptions without charge, although not all the qualifying conditions which provide exemption are necessarily life-long.The five-year duration ensures that a patient’s continued eligibility is confirmed by a health professional, whilst minimising the burden on the patient and healthcare staff and creating a check point at least once every five years on the accuracy of patient details for verification of claims for exemption and for fraud detection purposes.Therefore, there are currently no plans to review the duration of medical exemption certificates for people with type 1 diabetes and other lifelong conditions.
What assessment his Department has made of the potential impact of the use of covid vaccines on levels of (a) hospitalisations and (b) disability caused by long covid.
The Government is committed to protecting those most vulnerable to COVID-19 through vaccination as guided by the independent Joint Committee on Vaccination and Immunisation (JCVI). The JCVI assessment indicates that the oldest age cohorts and individuals who are immunosuppressed are the two groups who continue to be at higher risk of serious disease.To inform JCVI considerations, the last assessment of the impact of COVID-19 vaccines on hospitalisations was conducted by the UK Health Security Agency using data from the 2023 spring and autumn COVID-19 vaccination programmes. The next evaluation is planned to occur in the next few months.Long term health consequences following COVID-19, including post-COVID syndromes such as long COVID, have been discussed at meetings of the JCVI. It remains uncertain whether getting extra COVID-19 vaccine doses has any effect on the chances of developing long COVID, how it progresses, or how it affects people.
What steps his Department is taking to expedite decisions on access to new treatments for secondary breast cancer.
The National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether new licensed medicines should be routinely funded by the NHS based on an assessment of clinical and cost effectiveness. The NHS is legally required to fund NICE recommended medicines, normally within three months of final guidance, and cancer medicines are eligible for funding from the point of a positive draft NICE recommendation.NICE aims, wherever possible, to issue guidance on new medicines close to the time of licensing to ensure that patients are able to benefit from rapid access to clinically and cost effective new medicines. The Life Sciences Sector Plan sets out the measures we are taking that will mean that patients are able to access medicines three to six months faster, including improved alignment between the Medicines and Healthcare products Regulatory Agency’s decisions and NICE’s guidance publication. The Life Sciences Sector Plan is published and available at the following link:https://assets.publishing.service.gov.uk/media/688c90a8e8ba9507fc1b090c/Life_Sciences_Sector_Plan.pdf
What steps his Department is taking to reduce waiting times for NHS-provided wheelchairs for adults with degenerative neurological conditions.
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchair services.NHS England is taking a number of steps to reduce regional variation in the quality and provision of NHS wheelchairs, and to support ICBs to reduce delays in people receiving intervention and equipment. This includes publishing a Wheelchair Quality Framework on 9 April which sets out quality standards and statutory requirements for ICBs, such as offering personal wheelchair budgets. The framework is available at the following link:https://www.england.nhs.uk/long-read/wheelchair-quality-framework/The Government is committed to improving care for people with neurological conditions and ensuring that they receive the support they need. There are several initiatives at a national level supporting service improvement and better care for people with neurological conditions. These include the RightCare Progressive Neurological Conditions Toolkit, within which timely access to specialist and personalised equipment, such as wheelchairs, is a key area of focus.
Whether his Department plans to review the (a) application process and (b) delivery timescales for the Disabled Facilities Grant.
The Government has no immediate plans to review the application process or delivery timescales for the Disabled Facilities Grant (DFG). We continue to keep all aspects of the DFG under consideration. Recently, we carried out a review of the upper limit for the DFG and are currently considering the findings.The Department of Health and Social Care and the Ministry of Housing, Communities and Local Government share policy responsibility for the DFG. We also work with other Government Departments more widely on relevant issues.
Whether he plans to extend shingles vaccine eligibility to all immunocompetent people aged over 65.
In 2019, the Joint Committee on Vaccination and Immunisation (JCVI) advised that the shingles vaccination programme should switch to using a two-dose vaccine called Shingrix, to better protect individuals from the effects of shingles, provide better clinical outcomes, and reduce pressures on the health system. The committee also advised that the vaccine should be given to everyone at the age of 60 years old, rather than 70 years old.Based on this advice, the Department, the UK Health Security Agency, and NHS England decided to phase the expansion of the shingles programme. During the first phase, which commenced in September 2023, those who reach the ages of 65 or 70 years old will be called in for vaccination on or after their 65th or 70th birthday. During the second phase, from September 2028, individuals will be called in for vaccination on or after their 60th or 65th birthday. From 1 September 2033 onwards, vaccination will be routinely offered to those turning 60 years of age on or after their 60th birthday.Phasing the roll-out of the shingles vaccination over time to everyone aged 60 years old maximises cost-effectiveness and population benefit, ensures consistent messaging over time to maximise coverage, and takes account of National Health Service capacity, all while being consistent with the approach taken by all four nations in the United Kingdom.This is a newly expanded programme and anyone who is unsure if they are eligible for the shingles vaccination should check online, on the NHS.UK website, or should speak to their general practice.In November 2024, the JCVI provided further advice to the Department on eligibility for the shingles vaccination programme. This included advice that the Government should consider expanding the shingles vaccination offer to include older adult cohorts aged 80 years old and over. The Government will consider this latest advice when setting the policy on who should be offered shingles vaccinations, and will update in due course.
Whether his Department has made an assessment of the potential merits of introducing a requirement for self-employed carers to be regulated by the Care Quality Commission.
The Department has understood that the term ‘self-employed carer’ refers to self-employed personal assistants. There are no current plans to introduce a requirement for self-employed carers to be regulated by the Care Quality Commission (CQC).Currently, a person, or a related third party on their behalf, can make their own arrangement for personal care where an individual works directly for that person and under their control, without involving an agency or employer in managing or directing the care provided. In this case, the individual engaged does not need to register with the CQC for the regulated activity of personal care.